Cidara Therapeutics, Inc. (CDTX)
220.65
+0.46
(+0.21%)
USD |
NASDAQ |
Dec 12, 16:00
220.65
0.00 (0.00%)
After-Hours: 20:00
Cidara Therapeutics Research and Development Expense (Annual): 71.88M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Merck & Co., Inc. | 15.79B |
| Mersana Therapeutics, Inc. | 73.02M |
| Bristol Myers Squibb Co. | 9.782B |
| Johnson & Johnson | 17.26B |
| Pfizer Inc. | 10.74B |